ClinicalTrials.Veeva

Menu
E

Eye Clinic Albury Wodonga | Albury, Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KHK4951
AB154
VX-01
Triamcinolone Acetonide
Faricimab
ANX007

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 8 total trials

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA) (ARCHER II)

The primary purpose of the study is to determine if IVT injections of ANX007 every month reduce vision loss in participants with GA secondary to age-...

Enrolling
Geographic Atrophy
Drug: ANX007
Other: Sham Administration

The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of VX-01 as stand-alone treatmen...

Enrolling
NPDR - Non Proliferative Diabetic Retinopathy
Diabetic Retinopathy
Drug: VX-01
Drug: Placebo

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME.

Enrolling
Diabetic Macular Edema (DME)
Drug: KHK4951
Drug: Aflibercept Injection

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD.

Enrolling
Neovascular Age-Related Macular Degeneration (nAMD)
Drug: Aflibercept Injection
Drug: KHK4951

This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.

Active, not recruiting
Diabetic Macular Edema
Drug: Faricimab

Trial sponsors

Kyowa Kirin logo
A
Arcus Biosciences logo
C
Ionis Pharmaceuticals logo
McMaster University logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems